Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jan;93(1):165–171. doi: 10.1172/JCI116940

Increased production of nitric oxide in coronary arteries during congestive heart failure.

B O'Murchu 1, V M Miller 1, M A Perrella 1, J C Burnett Jr 1
PMCID: PMC293749  PMID: 8282783

Abstract

Experiments were designed to determine whether a heterogeneity of endothelium-dependent relaxations in arteries from different vascular beds exists in experimental congestive heart failure (CHF) and to determine the mediators of those responses. CHF was produced in dogs by rapid ventricular pacing for 15 d. Rings of coronary, femoral, and renal arteries with and without endothelium from control and CHF dogs were suspended in organ chambers for measurement of isometric force. In arteries contracted with prostaglandin F2 alpha, endothelium-dependent relaxations to BHT 920 (an alpha 2-adrenergic agonist) were increased in coronary arteries from dogs with CHF (maximal relaxation: control -15 +/- 9% vs CHF -92 +/- 5%; n = 5-6; P < 0.05), with a modest enhancement in renal arteries. Relaxations to adenosine diphosphate and the calcium ionophore were unchanged. Relaxations to BHT 920 in CHF were reduced by NG monomethyl-L-arginine (L-NMMA) and pertussis toxin but not by indomethacin. These data suggest that endothelium-dependent relaxations are affected heterogeneously in CHF. The enhanced response to alpha 2-adrenergic agonists in the coronary artery is mediated by nitric oxide through a mechanism sensitive to inhibition by pertussis toxin. This selective increase in endothelium-dependent relaxations in the coronary artery may contribute to preserving coronary blood flow during CHF.

Full text

PDF
165

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A., Cocks T. M., Satoh K. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol. 1986 Aug;88(4):767–777. doi: 10.1111/j.1476-5381.1986.tb16249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  3. Bristow M. R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986 Sep;59(3):297–309. doi: 10.1161/01.res.59.3.297. [DOI] [PubMed] [Google Scholar]
  4. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  5. Casey P. J., Gilman A. G. G protein involvement in receptor-effector coupling. J Biol Chem. 1988 Feb 25;263(6):2577–2580. [PubMed] [Google Scholar]
  6. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  7. DONALD K. W. Exercise and heart disease; a study in regional circulation. Br Med J. 1959 Apr 18;1(5128):985–994. doi: 10.1136/bmj.1.5128.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drexler H., Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol. 1992 Jun;262(6 Pt 2):H1640–H1645. doi: 10.1152/ajpheart.1992.262.6.H1640. [DOI] [PubMed] [Google Scholar]
  9. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  10. Dzau V. J., Packer M., Lilly L. S., Swartz S. L., Hollenberg N. K., Williams G. H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med. 1984 Feb 9;310(6):347–352. doi: 10.1056/NEJM198402093100603. [DOI] [PubMed] [Google Scholar]
  11. Feldman A. M., Cates A. E., Veazey W. B., Hershberger R. E., Bristow M. R., Baughman K. L., Baumgartner W. A., Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988 Jul;82(1):189–197. doi: 10.1172/JCI113569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Feldman M. D., Copelas L., Gwathmey J. K., Phillips P., Warren S. E., Schoen F. J., Grossman W., Morgan J. P. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987 Feb;75(2):331–339. doi: 10.1161/01.cir.75.2.331. [DOI] [PubMed] [Google Scholar]
  13. Flaim S. F., Minteer W. J. Ventricular volume overload alters cardiac output distribution in rats during exercise. J Appl Physiol Respir Environ Exerc Physiol. 1980 Sep;49(3):482–490. doi: 10.1152/jappl.1980.49.3.482. [DOI] [PubMed] [Google Scholar]
  14. Flavahan N. A., Rimele T. J., Cooke J. P., Vanhoutte P. M. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther. 1984 Sep;230(3):699–705. [PubMed] [Google Scholar]
  15. Fowler M. B., Laser J. A., Hopkins G. L., Minobe W., Bristow M. R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986 Dec;74(6):1290–1302. doi: 10.1161/01.cir.74.6.1290. [DOI] [PubMed] [Google Scholar]
  16. Horwitz L. D., Curry G. C., Parkey R. W., Bonte F. J. Effect of isoproterenol on coronary blood flow in primary myocardial disease. Circulation. 1974 Sep;50(3):560–564. doi: 10.1161/01.cir.50.3.560. [DOI] [PubMed] [Google Scholar]
  17. Houston D. S., Shepherd J. T., Vanhoutte P. M. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides. J Clin Invest. 1986 Aug;78(2):539–544. doi: 10.1172/JCI112606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kaiser L., Spickard R. C., Olivier N. B. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol. 1989 Apr;256(4 Pt 2):H962–H967. doi: 10.1152/ajpheart.1989.256.4.H962. [DOI] [PubMed] [Google Scholar]
  19. Katz S. D., Biasucci L., Sabba C., Strom J. A., Jondeau G., Galvao M., Solomon S., Nikolic S. D., Forman R., LeJemtel T. H. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992 Apr;19(5):918–925. doi: 10.1016/0735-1097(92)90271-n. [DOI] [PubMed] [Google Scholar]
  20. Komori K., Lorenz R. R., Vanhoutte P. M. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol. 1988 Jul;255(1 Pt 2):H207–H212. doi: 10.1152/ajpheart.1988.255.1.H207. [DOI] [PubMed] [Google Scholar]
  21. Kubo S. H., Rector T. S., Bank A. J., Williams R. E., Heifetz S. M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991 Oct;84(4):1589–1596. doi: 10.1161/01.cir.84.4.1589. [DOI] [PubMed] [Google Scholar]
  22. Main J. S., Forster C., Armstrong P. W. Inhibitory role of the coronary arterial endothelium to alpha-adrenergic stimulation in experimental heart failure. Circ Res. 1991 Apr;68(4):940–946. doi: 10.1161/01.res.68.4.940. [DOI] [PubMed] [Google Scholar]
  23. Margulies K. B., Hildebrand F. L., Jr, Lerman A., Perrella M. A., Burnett J. C., Jr Increased endothelin in experimental heart failure. Circulation. 1990 Dec;82(6):2226–2230. doi: 10.1161/01.cir.82.6.2226. [DOI] [PubMed] [Google Scholar]
  24. Miller V. M., Aarhus L. L., Vanhoutte P. M. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol. 1986 Sep;251(3 Pt 2):H520–H527. doi: 10.1152/ajpheart.1986.251.3.H520. [DOI] [PubMed] [Google Scholar]
  25. Nitenberg A., Foult J. M., Blanchet F., Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol. 1985 Mar 1;55(6):748–754. doi: 10.1016/0002-9149(85)90150-x. [DOI] [PubMed] [Google Scholar]
  26. Ontkean M., Gay R., Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res. 1991 Oct;69(4):1088–1096. doi: 10.1161/01.res.69.4.1088. [DOI] [PubMed] [Google Scholar]
  27. Opherk D., Schwarz F., Mall G., Manthey J., Baller D., Kübler W. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol. 1983 Jun;51(10):1657–1662. doi: 10.1016/0002-9149(83)90205-9. [DOI] [PubMed] [Google Scholar]
  28. Perrella M. A., Schwab T. R., O'Murchu B., Redfield M. M., Wei C. M., Edwards B. S., Burnett J. C., Jr Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am J Physiol. 1992 Apr;262(4 Pt 2):H1248–H1255. doi: 10.1152/ajpheart.1992.262.4.H1248. [DOI] [PubMed] [Google Scholar]
  29. Pirotton S., Raspe E., Demolle D., Erneux C., Boeynaems J. M. Involvement of inositol 1,4,5-trisphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells. J Biol Chem. 1987 Dec 25;262(36):17461–17466. [PubMed] [Google Scholar]
  30. Redfield M. M., Edwards B. S., McGoon M. D., Heublein D. M., Aarhus L. L., Burnett J. C., Jr Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog. Circulation. 1989 Sep;80(3):651–657. doi: 10.1161/01.cir.80.3.651. [DOI] [PubMed] [Google Scholar]
  31. Rees D. D., Palmer R. M., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989 May;86(9):3375–3378. doi: 10.1073/pnas.86.9.3375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shimokawa H., Flavahan N. A., Vanhoutte P. M. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res. 1989 Sep;65(3):740–753. doi: 10.1161/01.res.65.3.740. [DOI] [PubMed] [Google Scholar]
  33. Szatalowicz V. L., Arnold P. E., Chaimovitz C., Bichet D., Berl T., Schrier R. W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981 Jul 30;305(5):263–266. doi: 10.1056/NEJM198107303050506. [DOI] [PubMed] [Google Scholar]
  34. Thomas J. A., Marks B. H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978 Feb;41(2):233–243. doi: 10.1016/0002-9149(78)90162-5. [DOI] [PubMed] [Google Scholar]
  35. Treasure C. B., Vita J. A., Cox D. A., Fish R. D., Gordon J. B., Mudge G. H., Colucci W. S., Sutton M. G., Selwyn A. P., Alexander R. W. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990 Mar;81(3):772–779. doi: 10.1161/01.cir.81.3.772. [DOI] [PubMed] [Google Scholar]
  36. Weiss M. B., Ellis K., Sciacca R. R., Johnson L. L., Schmidt D. H., Cannon P. J. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation. 1976 Sep;54(3):484–494. doi: 10.1161/01.cir.54.3.484. [DOI] [PubMed] [Google Scholar]
  37. Zelis R., Mason D. T., Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968 Apr;47(4):960–970. doi: 10.1172/JCI105788. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES